Down-Regulation of Store-Operated Ca2+ Entry and Na+ Ca2+ Exchange in MCF-7 Breast Cancer Cells by Pharmacological JAK3 Inhibition

Cell Physiol Biochem. 2016;38(4):1643-51. doi: 10.1159/000443104. Epub 2016 Apr 28.

Abstract

Background/aims: Oscillations of cytosolic Ca2+ activity ([Ca2+]i) participate in the orchestration of tumor cell proliferation. [Ca2+]i could be increased by intracellular Ca2+ release followed by store-operated Ca2+-entry (SOCE). [Ca2+]i could be decreased by Ca2+ extrusion via Na+/Ca2+ exchange. Mechanisms accomplishing SOCE include the pore-forming ion channel unit Orai1 and its regulator STIM1, Na+/Ca2+ exchanger isoforms include NCX1. In MCF-7 breast carcinoma cells Orai1 and NCX1 have previously been shown to be modified by pharmacological inhibition of Janus activated kinase JAK2. The present study explored whether SOCE and Na+/Ca2+ exchange are similarly sensitive to pharmacological JAK3 inhibition.

Methods: MCF-7 breast carcinoma cells were studied in the absence and presence of the JAK3 inhibitor WHI-P154 (22 µM). [Ca2+]i was estimated from Fura-2-fluorescence, SOCE from increase of [Ca2+]i following Ca2+ re-addition after Ca2+-store depletion with sarcoendoplasmatic Ca2+-ATPase (SERCA) inhibitor thapsigargin (1 µM), and Na+/Ca2+ exchanger activity from increase of [Ca2+]i following extracellular Na+ removal. Transcript levels were quantified with RT-PCR.

Results: Addition of ATP (100 µM) was followed by a rapid increase of [Ca2+]i, which was significantly blunted by WHI-P154. Thapsigargin-induced intracellular Ca2+ release was not appreciably influenced by WHI-P154. Subsequent SOCE was, however, significantly blunted by WHI-P154. WHI-P154 further significantly decreased Orai1 transcript levels. The increase of [Ca2+]i following extracellular Na+-removal and the NCX1 transcript levels were similarly decreased by WHI-P154.

Conclusions: The JAK3 inhibitor WHI-P154 decreases both, Orai1 and NCX1 transcript levels and thus impairs SOCE and Na+/Ca2+ exchange.

MeSH terms

  • Adenosine Triphosphate / pharmacology
  • Breast Neoplasms
  • Calcium / metabolism*
  • Down-Regulation / drug effects
  • Female
  • Fura-2 / chemistry
  • Fura-2 / metabolism
  • Humans
  • Janus Kinase 3 / antagonists & inhibitors
  • Janus Kinase 3 / metabolism*
  • MCF-7 Cells
  • ORAI1 Protein / genetics
  • ORAI1 Protein / metabolism
  • Quinazolines / pharmacology
  • Real-Time Polymerase Chain Reaction
  • Sarcoplasmic Reticulum Calcium-Transporting ATPases / antagonists & inhibitors
  • Sarcoplasmic Reticulum Calcium-Transporting ATPases / metabolism
  • Sodium-Calcium Exchanger / genetics
  • Sodium-Calcium Exchanger / metabolism*
  • Spectrometry, Fluorescence
  • TATA-Box Binding Protein / genetics
  • TATA-Box Binding Protein / metabolism
  • Thapsigargin / pharmacology

Substances

  • ORAI1 Protein
  • Quinazolines
  • Sodium-Calcium Exchanger
  • TATA-Box Binding Protein
  • TBP protein, human
  • WHI P154
  • sodium-calcium exchanger 1
  • Thapsigargin
  • Adenosine Triphosphate
  • Janus Kinase 3
  • Sarcoplasmic Reticulum Calcium-Transporting ATPases
  • Calcium
  • Fura-2